Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors
Latest Information Update: 20 Dec 2010
At a glance
- Drugs Saracatinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Biomarker; Pharmacodynamics
Most Recent Events
- 20 Dec 2010 New trial record